Combination mRNA COVID-Influenza Shot Recommended by European Medicines Agency
The European Medicine Agency (EDA) has recommended marketing authorization for Moderna’s mCombriax mRNA (messenger ribonucleic acid) shot. The product, also known as mRNA-1083, is a genetically engineered biologic targeting both influenza and COVID-19. It builds on work Moderna has done on its next-generation mRNA COVID shot known as mNexSpike and mRNA-1010.1 2 3 The recommendation […]
Moderna Offered Children £1,500 to Enroll in COVID Booster Shot Trial
The Prescription Medicines Code of Practice Authority (PMCPA), an organization responsible for overseeing the marketing practices of pharmaceutical companies in the United Kingdom, criticized Moderna, Inc. for sending an unauthorized WhatsApp message that proposed a payment of £1,500 (about $2,000) to children for participating in a clinical trial for its COVID-19 booster shot.1 Complaint Filed […]